Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide

Prog Clin Biol Res. 1982:89:479-502.
No abstract available

MeSH terms

  • Adenocarcinoma / physiopathology*
  • Animals
  • Arginine / analogs & derivatives*
  • Arginine / pharmacology
  • Cell Line
  • Cell Transformation, Viral
  • Colonic Neoplasms / physiopathology*
  • Complement Inactivator Proteins / pharmacology
  • Dansyl Compounds*
  • Humans
  • Melanoma / physiopathology*
  • Mice
  • Neoplasm Metastasis
  • Neoplasms, Experimental / physiopathology
  • Platelet Aggregation* / drug effects
  • Rabbits
  • Simian virus 40 / genetics

Substances

  • Complement Inactivator Proteins
  • Dansyl Compounds
  • dansylarginine N-(3-ethyl-1,5-pentanediyl)amide
  • Arginine